Advik Laboratories Ltd — Important, 13-04-2026: Company Update

MPS Pharmaa Limited reported zero investor complaints for the quarter ending March 31. The company began the quarter with no pending complaints, received no new complaints, and consequently disposed of zero complaints, leaving no unresolved issues by the quarter's end. This reflects efficient investor grievance redressal and strong operational management, which is positive for shareholder confidence.